Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/1995
03/30/1995WO1995008339A1 Treatment or prevention of crohn's disease and/or ulcerative colitis
03/30/1995WO1995008338A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair
03/30/1995CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995CA2172494A1 Use of angiotensin ii analogs in tissue repair
03/30/1995CA2172491A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995CA2149783A1 Novel peptides
03/29/1995EP0644897A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors
03/29/1995EP0644895A1 Active component of parathyroid hypertensive factor
03/29/1995EP0644778A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING.
03/29/1995EP0644772A1 Opioid peptides
03/29/1995EP0644769A1 Biologically active peptides having n-terminal substitutions
03/29/1995EP0436005B1 Labeled polypeptide derivatives
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401648 Peptides having peptidyl transferase inhibiting activity and methods of use thereof
03/28/1995US5401628 Polypeptides derived from the human immunodeficiency virus endonuclease protein
03/28/1995US5401627 Warts, cancer
03/28/1995US5401378 Ionic reservoir at electrode surface
03/28/1995CA1334943C Leader sequence for the production of recombinant proteins
03/23/1995WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
03/23/1995WO1995007707A1 Alteration of immune response using pan dr-binding peptides
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995007705A1 Method for inhibiting vascular leakage and anti-inflammatory compounds
03/23/1995WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides
03/22/1995EP0644202A1 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/22/1995EP0644199A1 Cyclic antimicrobial peptides and preparation thereof
03/22/1995EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
03/22/1995EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
03/22/1995EP0643725A1 Single chain peptide compounds having hemoregulatory activity
03/22/1995EP0643706A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
03/22/1995EP0495877B1 Methods and compositions for healing bone
03/22/1995EP0449958B1 Meningococcal class 1 outer-membrane protein vaccine
03/22/1995EP0301087B1 Peptide
03/22/1995CN1100427A Purification of hepatic peptide and partial amino-acid series
03/21/1995US5399741 DNA gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
03/21/1995US5399552 Antibiotic peptides bearing aminoalkylthioether moieties
03/21/1995US5399490 Vector to produce biologically important peptides
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/16/1995WO1995007294A1 Pseudo- and non-peptide bradykinin receptor antagonists
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995WO1994026886A3 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
03/15/1995EP0643074A2 Viral infection and proliferation inhibitors
03/15/1995EP0642666A1 Hepatitis c assay
03/15/1995EP0642530A1 Derivatives of dolastatin
03/15/1995EP0642524A1 Systemin
03/15/1995EP0642357A1 Radiolabelled peptide compounds
03/15/1995CN1100104A New polypeptide compound and a process for preparation thereof
03/14/1995US5397694 For treatment of periodontal disease
03/14/1995CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics
03/14/1995CA2131755A1 Nucleic acid-binding oligomers possessing n-branching for therapy and diagnostics
03/09/1995WO1995006719A1 Method for specific immunoassay of human plasmatic glutathione peroxidase
03/09/1995CA2148268A1 Method for specific immunoassay of human plasmatic glutathione peroxidase
03/08/1995EP0641358A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/08/1995EP0641222A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
03/08/1995EP0500641B1 Control of milk secretion
03/08/1995EP0495013B1 Hexapeptides with sulphate ester groups
03/08/1995CN1099760A Cyclic adhesion inhibitors
03/07/1995US5395759 Vaccines, medical diagnosis
03/07/1995US5395609 Synthetic peptides for use in tumor detection
03/07/1995US5395594 Simultaneous multiple chemical synthesizer
03/02/1995WO1995006056A1 Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same
03/01/1995EP0640618A1 Tetrahydronaphthalene-peptide derivatives
03/01/1995EP0640133A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/01/1995EP0640101A1 Methods and reagents for diagnosis of autoantibodies
03/01/1995EP0640100A1 Modulation of thrombospondin-cd36 interactions
03/01/1995EP0518908B1 Method for polymerization of epoxide compounds
03/01/1995EP0406428B1 Peptide derivatives and their use
02/1995
02/28/1995US5393873 Peptides with anticoagulant activity
02/28/1995US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism
02/28/1995US5393740 Neurotensin Hexapeptides
02/28/1995US5393670 DNA, vectors and transformed hosts encoding Trichoderma reesei endoglucanase I
02/23/1995WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides
02/23/1995CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides
02/22/1995EP0639269A1 Ionic reservoir at electrode surface
02/22/1995EP0639202A1 Stable polypeptide composition
02/22/1995EP0438401B1 Combination lock for blood identification system
02/22/1995EP0229829B1 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
02/22/1995CN1099040A Linear adhesion inhibitor
02/21/1995US5391711 Biotinylating reagent and purification process for synthesized peptide using thereof
02/21/1995CA2006144C Microbial process for the production of immunosuppressive antibiotics
02/16/1995WO1995004752A1 Therapeutic peptide derivatives
02/16/1995WO1995004718A1 4-methyleneproline derivatives as fungicides
02/16/1995WO1995004543A1 Template assembled synthetic protein
02/16/1995WO1995004541A1 N-terminus modified analogs of lhrh
02/16/1995WO1995004540A1 N-terminus modified analogs of lhrh
02/16/1995CA2169284A1 Template assembled synthetic protein
02/16/1995CA2167834A1 N-terminus modified analogs of lhrh
02/15/1995EP0638588A1 Derivatives of 6,7-Dihydroxy-4-thiaheptonic acid and their use
02/15/1995EP0638123A1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
02/15/1995EP0638092A1 Synthetic peptide vaccines for dental caries
02/15/1995EP0637968A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
02/15/1995EP0573538B1 Peptides for treatment
02/14/1995US5389613 Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis
02/14/1995US5389381 Administering superoxide dismutase bound to low diol polyoxyethylene glycol with buffers and protective cyclodextrins
02/10/1995EP0661988A4 Composition and treatment with biologically active peptides and chelating agents.
02/09/1995WO1995004282A1 Immunoassay for detecting collagen or collagen fragments
02/09/1995WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents
02/09/1995WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
02/09/1995CA2167496A1 Immunoassay for the detection of collagen or collagen fragments
02/08/1995EP0637337A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
1 ... 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 ... 423